Feedback and Psychotherapeutic Competencies

Mental Disorders Clinical Trial

Official title:

Impact of Feedback on the Devolpment of Psychotherapeutic Competencies: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01986517
• Other study ID #: Feedback-01
• Status: Completed
• Phase: N/A
• First received: November 11, 2013
• Last updated: March 19, 2015
• Start date: November 2013
• Est. completion date: March 2015

Study information

• Verified date: March 2015
• Source: Goethe University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics committee of University Hospital Frankfurt Goethe University
• Study type: Interventional

Clinical Trial Summary

The purpose of the current study is to examine the influence of feedback on psychotherapeutic competency. The present randomized controlled study compares a feedback condition with a non-feedback condition. Therapists in the feedback condition receive feedback after every fourth session. The feedback is given by two trained and independent raters. The raters are licenced and experienced psychotherapists. Therapists in the non-feedback condition receive no feedback during the psychotherapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: March 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Therapists

Inclusion Criteria:

• Having successfully completed the interim audit

• Having started to treat ambulant patients

• Remaining at least 6 month in the ambulance

Exclusion Criteria:

Patients

Inclusion Criteria:

• Meeting ICD 10 criteria for a mental disorder

• Informed consent

Exclusion Criteria:

• Currently in psychotherapy

• Suicidal tendency

• Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder

• Clinical diagnosis of personality disorder cluster A (odd disorders) and B (dramatic, emotional or erratic)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Mental Disorders
• Psychotic Disorders

Intervention

Behavioral:
• No feedback
Therapists will receive no feedback.
• Feedback after every fourth session

Locations

Country	Name	City	State
Germany	Department of Clinical Psychology and Psychotherapy of Goethe University	Frankfurt/ Main	Hessen

Sponsors (1)

Lead Sponsor	Collaborator
Goethe University

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cognitive Therapy Scale (CTS)	external-assessment measure that assesses psychotherapeutic competency during a cognitive therapy session. CTS will be used by two trained raters licensed as psychological psychotherapists.	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Helping Alliance Questionaire (HAQ)	self-report measure to assess therapeutic alliance from the therapists perspective (therapist version; HAQ-T) and the patients perspective (HAQ-P)	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Berner Stundenbögen Version 2000	self-report measure to assess therapeutic relationship from the therapists perspective (therapist version, TSTB) and the patients perspective (patient version; PSTB)	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Global Assessment of Functioning (GAF)	external measure to assess the global functioning of the patient	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Supervisory Questionaire (SQ)	self-report measure to assess the therapists self-opening	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Supervisee Levels Questionaire (SLQ-R)	self-report measure to assess the therapists self-awareness	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Counseling Self-Estimate Inventory (COSE)	self-report measure to assess self efficacy of the therapist	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Fear of negative evaluation scale (Skala Angst vor negativer Bewertung; SANB)	self-report measure to assess fear of evaluation	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Brief Symptom Inventory (BSI)	self-report measure to assess aspects of general psychopathology	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Beck Depression Inventory II (BDI II)	self-report measure to assess depressive symptoms	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Beck Anxiety Inventory (BAI)	self-report measure to assess anxiety symptoms	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Client Satisfaction Questionaire (CSQ8)	self-report measure to assess satisfaction with therapy	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No
Secondary	Health-related quality of life (SF-12)	self-report measure to assess health-related quality of life	participants will be followed for the duration of psychotherapy, an expected average of 20 weeks	No